Protocol No
IOVANCE-IOV-GM1-201
Phase
I/II
Summary
This project is being done to find out whether the investigational drug, called IOV-4001, is safe and beneficial in the treatment of patients with unresectable or metastatic melanoma or advanced Non-Small Cell Lung Cancer (NSCLC).
Description
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov